Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
5-HT3 Antagonist
25%
Alder
25%
Antiemetics
100%
Cancer Chemotherapy
25%
Cardiff
50%
Chemotherapy
100%
Chemotherapy-induced Nausea
100%
Children with Cancer
100%
Children's Hospital
25%
Corticosteroids
25%
Embase
25%
Emetogenicity
75%
Evidence-based
25%
Evidence-based Approach
25%
Evidence-based Recommendations
25%
High-dose Chemotherapy
25%
Liverpool
50%
MEDLINE
25%
Nausea
25%
Oncology Center
25%
Pediatric Oncology
25%
Prescribed Dose
25%
Prescribing Practices
75%
Prophylactic Antiemetics
25%
Thromboprophylaxis
25%
Two-center
25%
Vomiting
25%
Welsh
50%
Nursing and Health Professions
Antiemetic Agent
100%
Cancer Chemotherapy
20%
Chemotherapy
100%
Chemotherapy Induced Nausea and Vomiting
100%
Childhood Cancer
20%
Clinical Audit
20%
Corticosteroid
20%
Embase
20%
Emetic Agent
20%
Malignant Neoplasm
100%
Medline
20%
Nausea and Vomiting
20%
Pediatric Hospital
20%
Serotonin 3 Antagonist
40%
Side Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alder
20%
Antiemetic Agent
100%
Cancer Chemotherapy
20%
Chemotherapy Induced Nausea and Vomiting
100%
Chemotherapy Regimens
100%
Childhood Cancer
20%
Corticosteroid
20%
Emetic Agent
20%
Malignant Neoplasm
100%
Nausea and Vomiting
20%
Serotonin 3 Antagonist
40%
Side Effect
20%
Neuroscience
5-HT3 Antagonist
33%
Antiemetic
83%
Chemotherapy
100%
Chemotherapy-Induced Nausea and Vomiting
100%
Corticosteroid
16%
Emetic Agent
16%
Pediatrics
16%
Side Effect
16%